• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,504.45 73.83
(0.71%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
29.975455
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
230.59
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales0.000.005.87
Other Operating Income1.290.000.71
Other Income 6.2935.460.03
Total Income7.5835.465.74
Total Expenditure 89.231.92181.72
PBIDT-81.6533.53-175.98
Interest 5.9030.220.00
PBDT-87.553.31-175.98
Depreciation0.080.060.20
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-19.71-11.02-0.18
Reported Profit After Tax-67.9214.27-176.01
Extra-ordinary Items -30.7134.80-175.68
Adjusted Profit After Extra-ordinary item-37.21-20.53-0.33
EPS (Unit Curr.)-3.380.64-7.84
EPS (Adj) (Unit Curr.)-3.380.64-7.84
Calculated EPS (Unit Curr.)-3.500.64-7.85
Calculated EPS (Adj) (Unit Curr.)-3.500.64-7.85
Calculated EPS (Ann.) (Unit Curr.)-13.982.55-31.39
Calculated EPS (Adj) (Ann.) (Unit Curr.)-13.982.55-31.39
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity19.4322.4322.43
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.000.00-3519.60
PBDTM(%)0.000.00-3519.60
PATM(%)0.000.00-3520.20